Isofagomine tartrate (planned trade name Plicera) is an experimental drug for the treatment of certain forms of Gaucher’s disease developed by Amicus Therapeutics and Shire plc.It has been granted orphan drug status by the European Medicines Agency (EMA). Isofagomine was invented by Mikael Bols and Troels Skrydstrup and was first prepared by Jespersen and Bols.
This page contains content from the copyrighted Wikipedia article "Isofagomine tartrate"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
